A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer

Clinical trial NCT00525408 · TERMINATED

Trial details

NCT number: NCT00525408
Sponsor: Cadila Pharnmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2007-11-01
Primary completion: 2013-01-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.